People default image

Jay Cormier

Jay KOR-mee-ayPartner
About

Jay Cormier advises pharmaceutical, biotechnology, and medical device companies on regulatory, transactional, compliance, and business matters across the product lifecycle. Drawing on experience in government, industry, and private practice, he helps businesses navigate the intersection of science, regulation, and commercial strategy.

A former reviewer at the United States Food and Drug Administration (FDA), Jay brings firsthand insight into FDA’s approach to product evaluation, regulatory decision-making, and submissions review. Prior to joining DLA Piper, he held executive operational roles at life sciences companies, giving him a practical understanding of the challenges organizations face when bringing products to market, managing risk, and pursuing growth. Jay provides strategic, business-oriented counsel that aligns regulatory compliance with broader corporate objectives.

Bar admissionsDistrict of ColumbiaMarylandMassachusettsNew York
Education
  • J.D., Georgetown University Law Center
  • Ph.D., Pharmacology, Columbia University
  • M.Phil., Columbia University
  • M.A., Columbia University
  • A.B., Dartmouth College

EXPERIENCE

  • Conducted legal, regulatory, and scientific due diligence for acquisitions and investments involving biotechnology and medical device companies
  • Advised life sciences companies before, during, and after FDA inspections, including current Good Manufacturing Practices (cGMP), Good Clinical Practice (GCP), and Good Laboratory Practice (GLP) regulatory reviews
  • Served as strategic regulatory counsel to biotechnology companies, supporting end-of-phase meetings, regulatory submissions, and advisory committee meetings, contributing to the approval of multiple New Drug Applications (NDAs) and complex supplemental applications

Prior Experience

Prior to joining DLA Piper, Jay served in several leadership roles for two biotechnology companies, including Vice President of Strategy and Operations, Chief Operating Officer, Senior Vice President, and Vice President of Legal and Regulatory Affairs. Before his biotechnology leadership roles, Jay served as an attorney at two Washington, DC-area law firms and as a pharmacologist at FDA.

Connect

Say Hello —